Article
Prognostic value of isocitrate dehydrogenase 1, O6-methylguanine-DNA methyltransferase promoter methylation, and 1p19q co-deletion in Japanese malignant glioma patients.
World journal of surgical oncology - 25 Oct 2013
Takahashi Yoshinobu, Nakamura Hideo, Makino Keishi, Hide Takuichiro, Muta Daisuke, Kamada Hajime, Kuratsu Jun-Ichi
Abstract excerpt
BACKGROUND: To determine the prognostic value of isocitrate dehydrogenase 1 (IDH1) mutation, O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation, and 1p/19q co-deletion in Japanese patients with malignant gliomas. METHODS: We studied 267 malignant gliomas, which included 171 glioblastomas (GBMs), 40 anaplastic astrocytomas (AAs), 30 anaplastic oligodendrogliomas (AOs), and 26 anaplastic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
